Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial

被引：0
|
作者：
Leila N. Atmowihardjo
Job R. Schippers
Erik Duijvelaar
Imke H. Bartelink
Pierre M. Bet
Noortje E. L. Swart
Nienke van Rein
Keith Purdy
David Cavalla
Andrew McElroy
Sarah Fritchley
Anton Vonk Noordegraaf
Henrik Endeman
Patricia van Velzen
Matty Koopmans
Harm Jan Bogaard
Leo Heunks
Nicole Juffermans
Marcus J. Schultz
Pieter R. Tuinman
Lieuwe D. J. Bos
Jurjan Aman
机构：
[1] Amsterdam UMC Location University of Amsterdam,Intensive Care
[2] Amsterdam University Medical Centers,Department of Pulmonary Medicine
[3] Location VUmc,Department of Clinical Pharmacology and Pharmacy
[4] Amsterdam UMC Location Vrije Universiteit Amsterdam,Department of Clinical Pharmacology and Pharmacy
[5] Amsterdam UMC Location University of Amsterdam,Department of Clinical Pharmacology and Pharmacy
[6] Leiden UMC,Intensive Care
[7] Exvastat,Intensive Care
[8] Erasmus University Medical Centre,Intensive Care
[9] Dijklander Hospital,Mahidol Oxford Tropical Medicine Research Unit (MORU)
[10] Location Purmerend,Nuffield Department of Medicine
[11] OLVG Hospital Location Oost,Department of Research and Development
[12] Mahidol University,Intensive Care
[13] University of Oxford,Laboratory of Translational Intensive Care
[14] Hamilton Medical AG,undefined
[15] Amsterdam UMC Location Vrije Universiteit Amsterdam,undefined
[16] Erasmus University,undefined
来源：
Critical Care | / 27卷
关键词：
COVID-19; ARDS; Imatinib; Vascular permeability; Endothelial barrier dysfunction; Pulmonary edema;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial
    Atmowihardjo, Leila N.
    Schippers, Job R.
    Duijvelaar, Erik
    Bartelink, Imke H.
    Bet, Pierre M.
    Swart, Noortje E. L.
    van Rein, Nienke
    Purdy, Keith
    Cavalla, David
    McElroy, Andrew
    Fritchley, Sarah
    Vonk Noordegraaf, Anton
    Endeman, Henrik
    van Velzen, Patricia
    Koopmans, Matty
    Bogaard, Harm Jan
    Heunks, Leo
    Juffermans, Nicole
    Schultz, Marcus J.
    Tuinman, Pieter R.
    Bos, Lieuwe D. J.
    Aman, Jurjan
    [J]. CRITICAL CARE, 2023, 27 (01)
  • [2] Cardiac Safety of Imatinib for the Treatment of COVID-19: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial
    Duijvelaar, Erik
    Vanhove, Arthur
    Schippers, Job R.
    Smeele, Patrick J.
    de Man, Frances S.
    Pinto, Yigal
    Aman, Jurjan
    Bogaard, Harm Jan
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 80 (06) : 783 - 791
  • [3] Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
    Aman, Jurjan
    Duijvelaar, Erik
    Botros, Liza
    Kianzad, Azar
    Schippers, Job R.
    Smeele, Patrick J.
    Azhang, Sara
    Bartelink, Imke H.
    Bayoumy, Ahmed A.
    Bet, Pierre M.
    Boersma, Wim
    Bonta, Peter, I
    Boomars, Karin A. T.
    Bos, Lieuwe D. J.
    Bragt, Job J. M. H. van
    Braunstahl, Gert-Jan
    Celant, Lucas R.
    Eger, Katrien A. B.
    Geelhoed, J. J. Miranda
    Glabbeek, Yurika L. E. van
    Grotjohan, Hans P.
    Hagens, Laura A.
    Happe, Chris M.
    Hazes, Boaz D.
    Heunks, Leo M. A.
    Heuvel, Michel van den
    Hoefsloot, Wouter
    Hoek, Rianne J. A.
    Hoekstra, Romke
    Hofstee, Herman M. A.
    Juffermans, Nicole P.
    Kemper, E. Marleen
    Kos, Renate
    Kunst, Peter W. A.
    Lammers, Ariana
    Lee, Ivo van der
    Lee, E. Laurien van der
    Zee, Anke-Hilse Maitland-van der
    Asam, Pearl F. M. Mau
    Mieras, Adinda
    Muller, Mirte
    Neefjes, Elisabeth C. W.
    Nossent, Esther J.
    Oswald, Laurien M. A.
    Overbeek, Maria J.
    Pamplona, Carolina C.
    Paternotte, Nienke
    Pronk, Niels
    Raaf, Michiel A. de
    Raaij, Bas F. M. van
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (09): : 957 - 968
  • [4] Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial
    Bosaeed, Mohammad
    Alharbi, Ahmad
    Mahmoud, Ebrahim
    Alrehily, Sanaa
    Bahlaq, Mohannad
    Gaifer, Zied
    Alturkistani, Hanan
    Alhagan, Khaled
    Alshahrani, Saad
    Tolbah, Ali
    Musattat, Abrar
    Alanazi, Maha
    Jaha, Raniah
    Sultana, Khizra
    Alqahtani, Hajar
    Al Aamer, Kholoud
    Jaser, Saud
    Alsaedy, Abdulrahman
    Ahmad, Ayoub
    Abalkhail, Mohammed
    AlJohani, Sameera
    Al Jeraisy, Majed
    Almaziad, Sultan
    Albaalharith, Nahlah
    Alabdulkareem, Khaled
    Alshowair, Abdulmajeed
    Alharbi, Naif Khalaf
    Alrabiah, Fahad
    Alshamrani, Majid
    Aldibasi, Omar
    Alaskar, Ahmed
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (04) : 602 - 608
  • [5] Cardiac Safety of Imatinib for the Treatment of Covid-19: Results from a Randomized, Double Blind, Placebo-Controlled Trial
    Duijvelaar, E.
    Vanhove, A.
    Schippers, J. R.
    Smeele, P. J.
    de Man, F. S.
    Pinto, Y. M.
    Bogaard, H. J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [6] Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Huang, Daniel Q.
    Ajmera, Veeral
    Tomaszewski, Christian
    LaFree, Andrew
    Bettencourt, Ricki
    Thompson, Wesley K.
    Smith, Davey M.
    Malhotra, Atul
    Mehta, Ravindra L.
    Tolia, Vaishal
    Yin, Jeffrey
    Insel, Paul A.
    Leachman, Stone
    Jung, Jinho
    Collier, Summer
    Richards, Lisa
    Woods, Kristin
    Amangurbanova, Maral
    Bhatt, Archana
    Zhang, Xinlian
    Penciu, Oana M.
    Zarich, Stuart
    Retta, Tamrat
    Harkins, Michelle S.
    Teixeira, J. Pedro
    Chinnock, Brian
    Utay, Netanya S.
    Lake, Jordan E.
    Loomba, Rohit
    [J]. ADVANCES IN THERAPY, 2023, 40 (11) : 4805 - 4816
  • [7] Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial
    Jain, Mamta K.
    De Lemos, James A.
    McGuire, Darren K.
    Ayers, Colby.
    Eitson, Jennifer L.
    Sanchez, Claudia L.
    Kamel, Dena
    Meisner, Jessica A.
    Thomas, Emilia V.
    Hegde, Anita A.
    Mocherla, Satish
    Strebe, Joslyn K.
    Li, Xilong
    Williams, Noelle S.
    Xing, Chao
    Ahmed, Mahmoud S.
    Wang, Ping
    Sadek, Hesham A.
    Schoggins, John W.
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [8] Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Daniel Q. Huang
    Veeral Ajmera
    Christian Tomaszewski
    Andrew LaFree
    Ricki Bettencourt
    Wesley K. Thompson
    Davey M. Smith
    Atul Malhotra
    Ravindra L. Mehta
    Vaishal Tolia
    Jeffrey Yin
    Paul A. Insel
    Stone Leachman
    Jinho Jung
    Summer Collier
    Lisa Richards
    Kristin Woods
    Maral Amangurbanova
    Archana Bhatt
    Xinlian Zhang
    Oana M. Penciu
    Stuart Zarich
    Tamrat Retta
    Michelle S. Harkins
    J. Pedro Teixeira
    Brian Chinnock
    Netanya S. Utay
    Jordan E. Lake
    Rohit Loomba
    [J]. Advances in Therapy, 2023, 40 : 4805 - 4816
  • [9] Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial
    Anan Manomaipiboon
    Kittisak Pholtawornkulchai
    Sujaree Poopipatpab
    Swangjit Suraamornkul
    Jakravoot Maneerit
    Wiroj Ruksakul
    Uraporn Phumisantiphong
    Thananda Trakarnvanich
    [J]. Trials, 23
  • [10] Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial
    Manomaipiboon, Anan
    Pholtawornkulchai, Kittisak
    Poopipatpab, Sujaree
    Suraamornkul, Swangjit
    Maneerit, Jakravoot
    Ruksakul, Wiroj
    Phumisantiphong, Uraporn
    Trakarnvanich, Thananda
    [J]. TRIALS, 2022, 23 (01)
12345